Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Kassam Zain — Finch Therapeutics Group, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Kassam Zain

Kassam Zain

Chief Medical Officer at Finch Therapeutics Group, Inc. · on record since Mar 18, 2021

Insider trading activity of Kassam Zain

Transactions on record: 1; since Mar 18, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 18, 2021

Figures computed from official regulatory filings — methodology.

Companies where Kassam Zain has traded

Finch Therapeutics Group, Inc.1 tx · Mar 18, 2021

Track record of Kassam Zain

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kassam Zain

Co-insiders of Kassam Zain

Blaustein MarcFinch Therapeutics Group, Inc.
Blischak Matthew P.Finch Therapeutics Group, Inc.
Crestovo Investor LLCFinch Therapeutics Group, Inc.
FERRANTE DOMENIC JFinch Therapeutics Group, Inc.
Graf Susan EFinch Therapeutics Group, Inc.
Haft NicholasFinch Therapeutics Group, Inc.
Hamood Samuel AFinch Therapeutics Group, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Lange Christian H.Finch Therapeutics Group, Inc.

PERRY GREGORY DFinch Therapeutics Group, Inc.

Shumway ChrisFinch Therapeutics Group, Inc.

SMISEK JEFFREY AFinch Therapeutics Group, Inc.

Smith Mark BurnhamFinch Therapeutics Group, Inc.

THIBAULT LANCE EFinch Therapeutics Group, Inc.

Viney Joanne L.Finch Therapeutics Group, Inc.

Vittiglio JosephFinch Therapeutics Group, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Finch Therapeutics Group, Inc.	Mar 18, 2021	AwardD	69,232	0.00 USD	$0	SEC